Intervention Review

Anti-spasticity agents for multiple sclerosis

  1. David Shakespeare1,*,
  2. Mike Boggild2,
  3. Carolyn A Young2

Editorial Group: Cochrane Multiple Sclerosis Group

Published Online: 20 OCT 2003

Assessed as up-to-date: 13 JUL 2003

DOI: 10.1002/14651858.CD001332


How to Cite

Shakespeare D, Boggild M, Young CA. Anti-spasticity agents for multiple sclerosis. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD001332. DOI: 10.1002/14651858.CD001332.

Author Information

  1. 1

    Lancashire Teaching Hospitals Trust, Neuro-rehabilitation Unit, Preston, Lancashire, UK

  2. 2

    The Walton Centre for Neurology & Neurosurgery, Liverpool, UK

*David Shakespeare, Neuro-rehabilitation Unit, Lancashire Teaching Hospitals Trust, 32A Watling Street Rd, Preston, Lancashire, PR2 8DY, UK. david.shakespeare@lthtr.nhs.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 OCT 2003

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.